Integrated Core Strategies (US) LLC 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:42 pm Sale | 2025-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 2,313,642 3.200% | -522,650 (-18.43%) | Filing |
| 2025-08-07 4:18 pm Purchase | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 2,836,292 5.300% | 902,913 (+46.70%) | Filing |
| 2025-04-28 4:03 pm Purchase | 2025-04-22 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 1,933,379 5.800% | 1,933,379 (New Position) | Filing |